Patents by Inventor Tomohiro Tsuda

Tomohiro Tsuda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11707488
    Abstract: An object of the present invention is to provide novel mesenchymal stem cells demonstrating superior therapeutic effects against various diseases, a novel pharmaceutical composition containing these mesenchymal stem cells, and a method for preparing the same. The present invention relates to ROR1-positive mesenchymal stem cells. The ROR1-positive mesenchymal stem cells are preferably positive for CD29, CD73, CD90, CD105 and CD166 and are derived from umbilical cord or adipose tissue.
    Type: Grant
    Filed: August 29, 2016
    Date of Patent: July 25, 2023
    Assignee: ROHTO PHARMACEUTICAL CO., LTD.
    Inventors: Yoshifumi Ikeyama, Hiroyuki Nishida, Tomohiro Tsuda, Eiko Uno, Masayo Yumoto, Kazuma Suda, Mihoko Yoshino, Xuan Trung Ngo
  • Patent number: 10929094
    Abstract: A method of controlling a device located in a predetermined space includes: obtaining sleep information of a person present in a first space from a biological sensor disposed in the first space, the sleep information indicating a sleep state of the person and the first space includes a first device; determining, by a processor, a first illuminance level to be set for the first device based on the obtained sleep information and a first database indicating a correspondence between the sleep state and a target illuminance level of a corresponding device, the target illuminance level of the corresponding device being a predetermined illuminance level which does not awake a sleeping person at the sleep state and provides visibility for an awake person; and transmitting, to the first device, a first command for setting the first illuminance level in the first device as an illuminance upper-limit value.
    Type: Grant
    Filed: July 11, 2019
    Date of Patent: February 23, 2021
    Assignee: PANASONIC INTELLECTUAL PROPERTY CORPORATION OF AMERICA
    Inventors: Kazuhiro Watanabe, Tomohiro Tsuda
  • Publication number: 20200069740
    Abstract: The purpose of the present invention is to provide the following: novel mesenchymal stem cells having an excellent therapeutic effect on various diseases, particularly diseases associated with fibrosis; and a pharmaceutical composition containing such mesenchymal stem cells. The present invention is a therapeutic agent for fibrosis that contains ROR1-positive mesenchymal stem cells and/or a culture supernatant thereof and that is for preventing or treating a disease associated with fibrosis. The mesenchymal stem cells are CD29-, CD73-, CD90-, CD105-, and CD166-positive and are preferably derived from the umbilical cord or fat. In addition, the abovementioned disease associated with fibrosis is preferably a liver disease, a lung disease, a kidney disease, or a heart disease.
    Type: Application
    Filed: March 8, 2018
    Publication date: March 5, 2020
    Applicant: ROHTO PHARMACEUTICAL CO., LTD.
    Inventors: Hikari Hasegawa, Masayo Yumoto, Yoshifumi Ikeyama, Hiroyuki Nishida, Tomohiro Tsuda, Eiko Uno, Kazuma Suda, Mihoko Yoshino, Xuan Trung Ngo
  • Publication number: 20190332351
    Abstract: A method of controlling a device located in a predetermined space includes: obtaining sleep information of a person present in a first space from a biological sensor disposed in the first space, the sleep information indicating a sleep state of the person and the first space includes a first device; determining, by a processor, a first illuminance level to be set for the first device based on the obtained sleep information and a first database indicating a correspondence between the sleep state and a target illuminance level of a corresponding device, the target illuminance level of the corresponding device being a predetermined illuminance level which does not awake a sleeping person at the sleep state and provides visibility for an awake person; and transmitting, to the first device, a first command for setting the first illuminance level in the first device as an illuminance upper-limit value.
    Type: Application
    Filed: July 11, 2019
    Publication date: October 31, 2019
    Applicant: PANASONIC INTELLECTUAL PROPERTY CORPORATION OF AMERICA
    Inventors: Kazuhiro WATANABE, Tomohiro TSUDA
  • Patent number: 10394517
    Abstract: A method of controlling a device located in a predetermined space includes: obtaining sleep information of a person present in a first space from a biological sensor disposed in the first space, the sleep information indicating a sleep state of the person and the first space includes a first device; determining, by a processor, a first sound volume to be set for the first device based on a first database indicating a correspondence between the sleep state and a target sound volume of a corresponding device, the target sound volume of the corresponding device being a predetermined sound volume which does not awake a sleeping person at the sleep state and still be heard by an awake person; and transmitting, to the first device, a first command for setting the first sound volume in the first device as a sound volume upper-limit value.
    Type: Grant
    Filed: January 30, 2017
    Date of Patent: August 27, 2019
    Assignee: PANASONIC INTELLECTUAL PROPERTY CORPORATION OF AMERICA
    Inventors: Kazuhiro Watanabe, Tomohiro Tsuda
  • Publication number: 20180333436
    Abstract: An object of the present invention is to provide novel mesenchymal stem cells demonstrating superior therapeutic effects against various diseases, a novel pharmaceutical composition containing these mesenchymal stem cells, and a method for preparing the same. The present invention relates to ROR1-positive mesenchymal stem cells. The ROR1-positive mesenchymal stem cells are preferably positive for CD29, CD73, CD90, CD105 and CD166 and are derived from umbilical cord or adipose tissue.
    Type: Application
    Filed: August 29, 2016
    Publication date: November 22, 2018
    Applicant: ROHTO PHARMACEUTICAL CO., LTD.
    Inventors: Yoshifumi Ikeyama, Hiroyuki Nishida, Tomohiro Tsuda, Eiko Uno, Masayo Yumoto, Kazuma Suda, Mihoko Yoshino, Xuan Trung Ngo
  • Publication number: 20180161262
    Abstract: The present invention relates to a cosmetic method comprising applying a migration imparting agent for adipose-derived stem cells to the skin, thereby allowing adipose-derived stem cells to migrate to the dermal layer and improving a skin condition. The present invention also relates to an external skin preparation for use in the cosmetic method, the external skin preparation comprising a migration imparting agent allowing adipose-derived stem cells to migrate to the dermal layer by application to the skin. The present invention further relates to a migration imparting agent for adipose-derived stem cells, comprising at least one of a polyol compound and a hydrophilic biomaterial. The present invention further relates to a method of screening for a component for use in a cosmetic method for improving a skin condition, comprising evaluating migratory activity of adipose-derived stem cells by using a prepared medium containing a sample.
    Type: Application
    Filed: May 26, 2016
    Publication date: June 14, 2018
    Applicant: ROHTO PHARMACEUTICAL CO., LTD.
    Inventors: Tomohiro Tsuda, Masayo Yumoto
  • Publication number: 20180066231
    Abstract: The present invention aims to provide a mesenchymal stem cell culture medium suitable for culturing umbilical cord mesenchymal stem cells in particular, among the mesenchymal stem cells. The present invention is of a mesenchymal stem cell culture medium comprising at least 2 kinds of components selected from the group consisting of a PTEN inhibitor, a p53 inhibitor, a p38 inhibitor, an Wnt signal activator and a ROCK inhibitor as well as basal medium for culturing animal cells.
    Type: Application
    Filed: February 26, 2016
    Publication date: March 8, 2018
    Applicant: ROHTO PHARMACEUTICAL CO., LTD.
    Inventors: Yoshifumi IKEYAMA, Toru OKUBO, Hiroyuki NISHIDA, Tomohiro TSUDA, Eiko UNO, Masayo YUMOTO
  • Publication number: 20170235542
    Abstract: A method of controlling a device located in a predetermined space includes: obtaining sleep information of a person present in a first space from a biological sensor disposed in the first space, the sleep information indicating a sleep state of the person and the first space includes a first device; determining, by a processor, a first sound volume to be set for the first device based on a first database indicating a correspondence between the sleep state and a target sound volume of a corresponding device, the target sound volume of the corresponding device being a predetermined sound volume which does not awake a sleeping person at the sleep state and still be heard by an awake person; and transmitting, to the first device, a first command for setting the first sound volume in the first device as a sound volume upper-limit value.
    Type: Application
    Filed: January 30, 2017
    Publication date: August 17, 2017
    Inventors: KAZUHIRO WATANABE, TOMOHIRO TSUDA
  • Patent number: 7548751
    Abstract: Adjacent base stations transmit and receive a signal using a plurality of carriers (frequencies), for example, f1 through f3. One base station has the largest transmission power for the carrier f1 and the smallest transmission power for the carrier f3. Another base station has the smallest transmission power for the carrier f1 and the largest transmission power for the carrier f3. Each of the carriers f1 through f3 has a different boundary positions.
    Type: Grant
    Filed: December 10, 2004
    Date of Patent: June 16, 2009
    Assignee: Fujitsu Limited
    Inventors: Masato Katori, Makoto Ueno, Masao Ootsuka, Tomohiro Tsuda, Kengo Kawamura, Motoyuki Tanaka
  • Publication number: 20080250379
    Abstract: In a logic circuit synthesis device, a library of cell preliminarily stores a condition concerning a property that should be satisfied by the net having the property. The logic circuit synthesis device selects, from a list of nets, a net that has a predetermined property. the logic circuit synthesis device performs logic synthesis in accordance with the condition stored in the library, for the selected net.
    Type: Application
    Filed: November 29, 2007
    Publication date: October 9, 2008
    Inventors: Shoji TAKAOKA, Atsushi Yamamoto, Tomohiro Tsuda, Takashi Hiramatsu
  • Publication number: 20050272431
    Abstract: Adjacent base stations transmit and receive a signal using a plurality of carriers (frequencies), for example, f1 through f3. One base station has the largest transmission power for the carrier f1 and the smallest transmission power for the carrier f3. Another base station has the smallest transmission power for the carrier f1 and the largest transmission power for the carrier f3. Each of the carriers f1 through f3 has a different boundary positions.
    Type: Application
    Filed: December 10, 2004
    Publication date: December 8, 2005
    Inventors: Masato Katori, Makoto Ueno, Masao Ootsuka, Tomohiro Tsuda, Kengo Kawamura, Motoyuki Tanaka